DAVID DEGRASSI: Open Payments
NPI 1891465043 · HUNTLEY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,633 in 44 payments from 15 companies in 2025. Trend: 2023 $455 · 2024 $1,289 · 2025 $1,633
Food & beverage: $1,534Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $502 |
| Astellas Pharma US Inc | 7 | $246 |
| Dendreon Pharmaceuticals LLC | 7 | $221 |
| Ferring Pharmaceuticals Inc. | 2 | $159 |
| UROGEN PHARMA, INC. | 1 | $109 |
| Sumitomo Pharma America, Inc. | 5 | $108 |
| ABBVIE INC. | 4 | $103 |
| Profound Medical Corp. | 2 | $42 |
| Olympus America Inc. | 1 | $34 |
| AVYXA PHARMA, LLC | 1 | $25 |
Products named: ERLEADA, PROVENGE, ADSTILADRIN, Xtandi, JELMYTO, GEMTESA, BOTOX, LUPRON DEPOT.
Industry payments across IL — which companies pay providers there.
